Many people experience effective appetite reduction and weight loss without any GI symptoms
Currently, Judy continues her work in primary care alongside Athena and brings extensive knowledge of GLP-1 medications
Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist for type 2 diabetes and weight management, which works by suppressing appetite, slowing gastric emptying, increasing feelings of fullness, and reducing calorie intake
as excess energy accumulates, white adipose tissue (WAT) cells undergo abnormal, hypertrophic growth, leading to poor blood supply (hypoxia), macrophage infiltration, and systemic inflammation
How Semaglutide Works And Why Side Effects Happen Semaglutide mimics a natural hormone (GLP-1) that helps your body release insulin when glucose is high, lowers glucagon, slows gastric emptying, and reduces appetite